ANIK Overview

Company Profile

Related stocks

IRWD • United States

Ironwood Pharmaceuticals, Inc.

3.82 USD

631.22M USD 1Y +144.9%

HROW • United States

Harrow, Inc.

29.36 USD

1.1B USD 1Y -23.2%

PCRX • United States

Pacira BioSciences, Inc.

36.31 USD

1.45B USD 1Y +55.4%

COLL • United States

Collegium Pharmaceutical, Inc.

22.09 USD

719.15M USD 1Y -33.3%

PAHC • United States

Phibro Animal Health Corporatio

38.3 USD

1.56B USD 1Y +0.8%

ANIP • United States

ANI Pharmaceuticals, Inc.

73.89 USD

1.7B USD 1Y -21.5%

PBH • United States

Prestige Consumer Healthcare In

48.23 USD

2.28B USD 1Y -24.4%

EOLS • United States

Evolus, Inc. Common Stock

7.73 USD

510.57M USD 1Y +25.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

United States

Region

North America

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

45.4% p.a.

Max Drawdown (5Y)

-82.0%

Sharpe Ratio (5Y)

-0.36

Beta Factor

0.21

Size Class

Micro Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -89.0% in the extended horizon.